Categories: Wire Stories

Aryballe Streamlines Odor Analysis with New Digital Olfaction Hardware and Software

New products will enable simpler use of digital olfaction across organizations

GRENOBLE, France–(BUSINESS WIRE)–Aryballe, the pioneer in digital olfaction, today introduced new hardware and software products that enable faster, simpler odor analysis. Available in Q1 2022, the latest additions to Aryballe�s solution suite will significantly improve user experience and reduce the need for operation by trained specialists.

Digital olfaction has come to the forefront as a new requirement for competing in the digital economy. Companies are now relying on digital olfaction to differentiate their offerings and operations, while ensuring the consistency of product quality throughout the manufacturing process.

The Aryballe Answers Module, a new software for quality control applications engineered to support the Aryballe NeOse Advance, enables users to set customizable parameters for odor analysis. It offers repeatable, fast pass/fail answers for odor comparison. Users can load reference odor samples from an existing database or perform direct comparisons on the spot. This simplified pass/fail analysis eliminates the need for a highly-trained analytical expert, enabling broader deployment across manufacturing, supply chain and other quality control applications.

Aryballe is expanding the usability of the NeOse Advance with the introduction of the Core Sensor Gen 1.5. The new Core Sensor streamlines the maintenance and odor analysis process and eliminates the need for specialized tools and technical training. Sensors can easily be replaced by users of any skill level in just one minute, compared to 15 minutes in the previous iteration, leading to less downtime and, in turn, faster and more frequent data collection.

“With the introduction of the Core Sensor Gen 1.5 and the Aryballe Answers Module, Aryballe is democratizing the power of digital olfaction. It empowers companies to perform faster, simpler odor analysis that drive impactful business decisions,” said Sam Guillaume, CEO, Aryballe. “In past iterations of digital olfaction technology, highly-trained analytical experts were needed to operate devices and interpret the analysis. Simple-to-replace core sensors and customizable pass/fail analysis make our technology and expertise more accessible to a wide variety of manufacturing, supply chain, and quality control end-users and enable customers to improve their quality control processes.”

The introduction of these new software and hardware products come as Aryballe continues to grow and establish new use cases in industries from flavor and fragrance to automotive and consumer packaged goods. In 2021, Aryballe introduced the NeOse Advance device, its first product based on silicon photonics that captures consistent odor data with improved reliability and stability.

The Aryballe Answers Module software will be available January 31, 2022 and Core Sensors will begin shipping March 31. Aryballe will showcase the Answers Module software during its upcoming webinar on January 19, 2022. To register and learn more, visit www.aryballe.com/fff-webinar

About Aryballe

Based in Grenoble, France and founded in 2014, Aryballe combines biochemistry, advanced optics and machine learning to mimic the human sense of smell. The company’s premier product offering, NeOse Advance, uses silicon photonics technology to detect, record and recognize odor data, which powers improved decision making for R&D, quality control, manufacturing and end-user experiences. Aryballe Suite, the company’s cloud-enabled software, enables customers to intuitively access and customize analysis of odors based on their unique needs. With operations in France, South Korea and the USA, Aryballe works with global leaders in automotive, food manufacturing and flavor & fragrances.

Contacts

Elizabeth Facteau

pr@aryballe.com
+1 518 429 7380

Alex

Recent Posts

Vinmec pioneers Southeast Asia’s first 3D-printed titanium chest wall reconstruction, opening new pathways in cardiac treatment

HANOI, VIETNAM – Media OutReach Newswire - 20 September 2024 - Doctors at Vinmec Times…

2 hours ago

GAMCO Investors, Inc. Announces Special Dividend of $2.00 per share

GREENWICH, Conn., Sept. 19, 2024 (GLOBE NEWSWIRE) -- GAMCO Investors, Inc. (“GAMCO”) (OTCQX: GAMI) today…

10 hours ago

YY Group Holding Limited Announces Unaudited First Half 2024 Financial Results

SINGAPORE, Sept. 10, 2024 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) (“YY Group”,…

10 hours ago

New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

PALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary -…

10 hours ago

Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

PALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary -…

10 hours ago

AFG Holding SA acquires Access Microfinance Holding AG

ABIDJAN, COTE D'IVOIRE - African Media Agency(AMA) - 19 September 2024 - AFG Holding SA…

10 hours ago